|
Biovail to Participate at Upcoming Conferences
|
11/10/09
|
Biovail to Participate at Upcoming Conferences
|
PDF
|
|
Biovail Reports Third-Quarter 2009 Financial Results
|
11/05/09
|
Biovail Reports Third-Quarter 2009 Financial Results
|
PDF
|
|
Biovail Declares Quarterly Dividend
|
11/05/09
|
Biovail Declares Quarterly Dividend
|
PDF
|
|
Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details
|
10/23/09
|
Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details
|
PDF
|
|
Biovail Receives 2009 Company of the Year Award from the Life Science Association of Manitoba
|
10/16/09
|
Biovail Receives 2009 Company of the Year Award from the Life Science Association of Manitoba
|
PDF
|
|
Biovail Provides Update on Pimavanserin Collaborative Development Program
|
10/06/09
|
Biovail Provides Update on Pimavanserin Collaborative Development Program
|
PDF
|
|
Biovail Participates at Upcoming Conferences
|
09/10/09
|
Biovail Participates at Upcoming Conferences
|
PDF
|
|
Biovail Announces Results from ACADIA's Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
|
09/01/09
|
Biovail Announces Results from ACADIA's Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
|
PDF
|
|
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
|
08/24/09
|
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
|
PDF
|
|
Biovail Comments on Ultram(R) ER Court Ruling
|
08/17/09
|
Biovail Comments on Ultram(R) ER Court Ruling
|
PDF
|
|
Biovail to Present at Canaccord Adams Global Growth Conference
|
08/10/09
|
Biovail to Present at Canaccord Adams Global Growth Conference
|
PDF
|
|
Biovail Reports Second-Quarter 2009 Financial Results
|
08/06/09
|
Biovail Reports Second-Quarter 2009 Financial Results
|
PDF
|
|
Biovail Launches Share Repurchase Program
|
08/06/09
|
Biovail Launches Share Repurchase Program
|
PDF
|
|
Biovail Declares Quarterly Dividend080609
|
08/06/09
|
Biovail Declares Quarterly Dividend080609
|
PDF
|
|
Biovail Announces Second-Quarter 2009 Earnings Release, Conference-Call Details
|
07/28/09
|
Biovail Announces Second-Quarter 2009 Earnings Release, Conference-Call Details
|
PDF
|
|
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
|
06/22/09
|
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
|
PDF
|
|
Biovail Announces New Increased Revolving Credit Facility
|
06/09/09
|
Biovail Announces New Increased Revolving Credit Facility
|
PDF
|
|
Biovail Announces Pricing of Offering of US$300 Million Senior Convertible Notes due 2014
|
06/03/09
|
Biovail Announces Pricing of Offering of US$300 Million Senior Convertible Notes due 2014
|
PDF
|
|
Biovail Announces Offering of Senior Convertible Notes
|
06/02/09
|
Biovail Announces Offering of Senior Convertible Notes
|
PDF
|
|
Biovail Corporation announced that the Company will participate at the UBS Global Specialty Pharmaceuticals Conference
|
05/29/09
|
Biovail Corporation announced that the Company will participate at the UBS Global Specialty Pharmaceuticals Conference
|
PDF
|
|
Biovail Announces Results of 2009 Annual and Special Meeting of Shareholders
|
05/28/09
|
Biovail Announces Results of 2009 Annual and Special Meeting of Shareholders
|
PDF
|
|
Biovail Waives Deadline for Submitting Proxies
|
05/26/09
|
Biovail Waives Deadline for Submitting Proxies
|
PDF
|
|
Biovail Announces Settlement of Proxy Contest
|
05/25/09
|
Biovail Announces Settlement of Proxy Contest
|
PDF
|
|
Biovail Advises Shareholders to Vote Their Blue Proxy Today
|
05/22/09
|
Biovail Advises Shareholders to Vote Their Blue Proxy Today
|
PDF
|
|
Biovail Announces That RiskMetrics, Glass Lewis and PROXY Governance All Recommend Voting the BLUE Proxy
|
05/19/09
|
Biovail Announces That RiskMetrics, Glass Lewis and PROXY Governance All Recommend Voting the BLUE Proxy
|
PDF
|
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
|
05/19/09
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
|
PDF
|
|
Biovail Announces Termination of HSR Waiting Period, Closing of Acquisition of U.S. Rights to Wellbutrin XL(R)
|
05/15/09
|
Biovail Announces Termination of HSR Waiting Period, Closing of Acquisition of U.S. Rights to Wellbutrin XL(R)
|
PDF
|
|
Biovail Receives 2009 Corporate Award from National Organization for Rare Disorders
|
05/15/09
|
Biovail Receives 2009 Corporate Award from National Organization for Rare Disorders
|
PDF
|
|
Biovail Advises Shareholders to Use Their Blue Proxy to Reject Melnyk Nominees
|
05/14/09
|
Biovail Advises Shareholders to Use Their Blue Proxy to Reject Melnyk Nominees
|
PDF
|
|
Biovail to Participate at Upcoming Conferences
|
05/11/09
|
Biovail to Participate at Upcoming Conferences
|
PDF
|
|
Biovail Announces Dismissal of Securities Litigation
|
05/11/09
|
Biovail Announces Dismissal of Securities Litigation
|
PDF
|
|
ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial
|
05/06/09
|
ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial
|
PDF
|
|
Biovail Reports First-Quarter 2009 Financial Results
|
05/06/09
|
Biovail Reports First-Quarter 2009 Financial Results
|
PDF
|
|
Biovail Declares Quarterly Dividend, Announces Change in Dividend Policy
|
05/06/09
|
Biovail Declares Quarterly Dividend, Announces Change in Dividend Policy
|
PDF
|
|
Biovail Announces Acquisition of U.S. Rights to Wellbutrin XL(R)
|
05/06/09
|
Biovail Announces Acquisition of U.S. Rights to Wellbutrin XL(R)
|
PDF
|
|
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
|
05/04/09
|
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
|
PDF
|
|
Biovail Announces First-Quarter 2009 Earnings Release, Conference-Call Details
|
05/01/09
|
Biovail Announces First-Quarter 2009 Earnings Release, Conference-Call Details
|
PDF
|
|
Biovail Issues Management Proxy Circular and Letter to Shareholders
|
04/30/09
|
Biovail Issues Management Proxy Circular and Letter to Shareholders
|
PDF
|
|
Biovail Appoints Fred Nicklas Vice-President, U.S. Commercial Operations
|
04/21/09
|
Biovail Appoints Fred Nicklas Vice-President, U.S. Commercial Operations
|
PDF
|
|
Biovail Announces U.S. Availability of Aplenzin(TM) Tablets
|
04/07/09
|
Biovail Announces U.S. Availability of Aplenzin(TM) Tablets
|
PDF
|
|
Biovail Appoints Rochelle Seide Ph.D., J.D. Vice-President, Intellectual Property
|
04/06/09
|
Biovail Appoints Rochelle Seide Ph.D., J.D. Vice-President, Intellectual Property
|
PDF
|
|
Biovail Announces Establishment of External Advisory Board
|
03/27/09
|
Biovail Announces Establishment of External Advisory Board
|
PDF
|
|
Biovail Announces Annual and Special Meeting of Shareholders
|
03/17/09
|
Biovail Announces Annual and Special Meeting of Shareholders
|
PDF
|
|
Biovail to Present at Barclays Capital Global Healthcare Conference
|
03/09/09
|
Biovail to Present at Barclays Capital Global Healthcare Conference
|
PDF
|
|
Biovail Reports Fourth Quarter, Year-End 2008 Financial Results
|
02/26/09
|
Biovail Reports Fourth Quarter, Year-End 2008 Financial Results
|
PDF
|
|
Biovail Declares Quarterly Dividend
|
02/26/09
|
Biovail Declares Quarterly Dividend
|
PDF
|
|
Biovail Receives Requisition from Dissident Shareholder Eugene Melnyk
|
02/25/09
|
Biovail Receives Requisition from Dissident Shareholder Eugene Melnyk
|
PDF
|
|
Biovail Announces Fourth-Quarter 2008 Earnings Release, Conference-Call Details
|
02/12/09
|
Biovail Announces Fourth-Quarter 2008 Earnings Release, Conference-Call Details
|
PDF
|
|
Biovail Announces Approval of Settlement Agreement with OSC
|
01/09/09
|
Biovail Announces Approval of Settlement Agreement with OSC
|
PDF
|
|
Biovail Reaches Settlement Agreement with OSC Staff
|
01/07/09
|
Biovail Reaches Settlement Agreement with OSC Staff
|
PDF
|